BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
International Journal of Molecular Sciences · 05.03.2023 · 24 (5) · 4982
DOI: 10.3390/ijms24054982 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.03.2023. Verfasst von Anna P Loboda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Phystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Resear…, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Two related tumor suppressor genes, BRCA1 and BRCA2, attract a lot of attention from both fundamental and clinical points of view. Oncogenic hereditary mutations in these genes are firmly linked to the early onset of breast and ovarian cancers. However, the molecular mechanisms that drive extensive mutagenesis in these genes are not known. In this review, we hypothesize that one of the potential mechanisms behind this phenomenon can be mediated by Alu mobile genomic elements. Linking mutations in the BRCA1 and BRCA2 genes to the general mechanisms of genome stability and DNA repair is critical to ensure the rationalized choice of anti-cancer therapy. Accordingly, we review the literature available on the mechanisms of DNA damage repair where these proteins are involved, and how the inactivating mutations in these genes (BRCAness) can be exploited in anti-cancer therapy. We also discuss a hypothesis explaining why breast and ovarian epithelial tissues are preferentially susceptible to mutations in BRCA genes. Finally, we discuss prospective novel therapeutic approaches for treating BRCAness cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Oncology, Phystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141701 Dolgoprudny, Russia.
- Institute of Biomedical Chemistry, 119121 Moscow, Russia.
- School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
- Group of Cross-Linking Enzymes, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, 117997 Moscow, Russia.
- Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products, 108819 Moscow, Russia.
- Institute of Cytology, Tikhoretsky ave 4, 194064 St-Petersburg, Russia.
ORCID-Profile: Leonid S Adonin, Dmitri Y Guschin
Förderung
- Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Resear…
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Loboda, A. P., Adonin, L. S., Zvereva, S. D., Guschin, D. Y., Korneenko, T. V., Telegina, A. V., Kondratieva, O. K., Frolova, S. E., Pestov, N. B., & Barlev, N. A. (2023). BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers. International Journal of Molecular Sciences, 24(5), 4982. https://doi.org/10.3390/ijms24054982
Vancouver
Loboda AP, Adonin LS, Zvereva SD, Guschin DY, Korneenko TV, Telegina AV, et al. BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers. International Journal of Molecular Sciences. 2023;24(5):4982. doi:10.3390/ijms24054982
BibTeX
@article{Loboda2023,
author = {Loboda, Anna P and Adonin, Leonid S and Zvereva, Svetlana D and Guschin, Dmitri Y and Korneenko, Tatyana V and Telegina, Alexandra V and Kondratieva, Olga K and Frolova, Sofia E and Pestov, Nikolay B and Barlev, Nick A},
title = {BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {5},
pages = {4982},
doi = {10.3390/ijms24054982}
}
EUVIMED